Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Cytotoxic effects of fucoidan nanoparticles against osteosarcoma.

Kimura R, Rokkaku T, Takeda S, Senba M, Mori N.

Mar Drugs. 2013 Oct 30;11(11):4267-78. doi: 10.3390/md11114267.

2.

Fucoidan Suppresses the Growth of Human Acute Promyelocytic Leukemia Cells In Vitro and In Vivo.

Atashrazm F, Lowenthal RM, Woods GM, Holloway AF, Karpiniec SS, Dickinson JL.

J Cell Physiol. 2016 Mar;231(3):688-97. doi: 10.1002/jcp.25119.

PMID:
26241708
3.
4.

Fucoidan from Sargassum sp. and Fucus vesiculosus reduces cell viability of lung carcinoma and melanoma cells in vitro and activates natural killer cells in mice in vivo.

Ale MT, Maruyama H, Tamauchi H, Mikkelsen JD, Meyer AS.

Int J Biol Macromol. 2011 Oct 1;49(3):331-6. doi: 10.1016/j.ijbiomac.2011.05.009. Epub 2011 May 23.

PMID:
21624396
5.

Development of tumor-specific caffeine-potentiated chemotherapy using a novel drug delivery system with Span 80 nano-vesicles.

Nakata H, Miyazaki T, Iwasaki T, Nakamura A, Kidani T, Sakayama K, Masumoto J, Miura H.

Oncol Rep. 2015 Apr;33(4):1593-8. doi: 10.3892/or.2015.3761. Epub 2015 Jan 29.

6.

Antitumor activity of fucoidan against diffuse large B cell lymphoma in vitro and in vivo.

Yang G, Zhang Q, Kong Y, Xie B, Gao M, Tao Y, Xu H, Zhan F, Dai B, Shi J, Wu X.

Acta Biochim Biophys Sin (Shanghai). 2015 Nov;47(11):925-31. doi: 10.1093/abbs/gmv094. Epub 2015 Sep 9.

PMID:
26358321
7.

Prophylactic administration of fucoidan represses cancer metastasis by inhibiting vascular endothelial growth factor (VEGF) and matrix metalloproteinases (MMPs) in Lewis tumor-bearing mice.

Huang TH, Chiu YH, Chan YL, Chiu YH, Wang H, Huang KC, Li TL, Hsu KH, Wu CJ.

Mar Drugs. 2015 Apr 3;13(4):1882-900. doi: 10.3390/md13041882.

8.

Fucoidan enhances intestinal barrier function by upregulating the expression of claudin-1.

Iraha A, Chinen H, Hokama A, Yonashiro T, Kinjo T, Kishimoto K, Nakamoto M, Hirata T, Kinjo N, Higa F, Tateyama M, Kinjo F, Fujita J.

World J Gastroenterol. 2013 Sep 7;19(33):5500-7. doi: 10.3748/wjg.v19.i33.5500.

9.

Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFβ receptor degradation in breast cancer.

Hsu HY, Lin TY, Hwang PA, Tseng LM, Chen RH, Tsao SM, Hsu J.

Carcinogenesis. 2013 Apr;34(4):874-84. doi: 10.1093/carcin/bgs396. Epub 2012 Dec 28.

PMID:
23275155
10.

Anti-tumor activity of fucoidan is mediated by nitric oxide released from macrophages.

Takeda K, Tomimori K, Kimura R, Ishikawa C, Nowling TK, Mori N.

Int J Oncol. 2012 Jan;40(1):251-60. doi: 10.3892/ijo.2011.1168. Epub 2011 Aug 18.

PMID:
21874230
11.

Using targeted magnetic arsenic trioxide nanoparticles for osteosarcoma treatment.

Li XS, Li WQ, Wang WB.

Cancer Biother Radiopharm. 2007 Dec;22(6):772-8.

PMID:
18158768
12.

Anticancer properties and mechanisms of fucoidan on mouse breast cancer in vitro and in vivo.

Xue M, Ge Y, Zhang J, Wang Q, Hou L, Liu Y, Sun L, Li Q.

PLoS One. 2012;7(8):e43483. doi: 10.1371/journal.pone.0043483. Epub 2012 Aug 20.

13.

Fucoidan protects against dopaminergic neuron death in vivo and in vitro.

Luo D, Zhang Q, Wang H, Cui Y, Sun Z, Yang J, Zheng Y, Jia J, Yu F, Wang X, Wang X.

Eur J Pharmacol. 2009 Sep 1;617(1-3):33-40. doi: 10.1016/j.ejphar.2009.06.015. Epub 2009 Jun 21.

PMID:
19545563
14.

Fucoidan present in brown algae induces apoptosis of human colon cancer cells.

Kim EJ, Park SY, Lee JY, Park JH.

BMC Gastroenterol. 2010 Aug 22;10:96. doi: 10.1186/1471-230X-10-96.

15.
16.

Fucoidan from Macrocystis pyrifera has powerful immune-modulatory effects compared to three other fucoidans.

Zhang W, Oda T, Yu Q, Jin JO.

Mar Drugs. 2015 Feb 19;13(3):1084-104. doi: 10.3390/md13031084.

17.

Fucoidan from Undaria pinnatifida induces apoptosis in A549 human lung carcinoma cells.

Boo HJ, Hyun JH, Kim SC, Kang JI, Kim MK, Kim SY, Cho H, Yoo ES, Kang HK.

Phytother Res. 2011 Jul;25(7):1082-6. doi: 10.1002/ptr.3489.

PMID:
21452391
18.

Development of Alendronate-conjugated Poly (lactic-co-glycolic acid)-Dextran Nanoparticles for Active Targeting of Cisplatin in Osteosarcoma.

Liu P, Sun L, Zhou DS, Zhang P, Wang YH, Li D, Li QH, Feng RJ.

Sci Rep. 2015 Dec 1;5:17387. doi: 10.1038/srep17387. Retraction in: Sci Rep. 2016 Sep 16;6:31938.

19.
20.

Determination of the active transport of fucoidan derived from Okinawa Mozuku across the human intestinal Caco-2 cells as assessed by size-exclusion chromatography.

Nagamine T, Hayakawa K, Nakazato K, Iha M.

J Chromatogr B Analyt Technol Biomed Life Sci. 2015 Aug 1;997:187-93. doi: 10.1016/j.jchromb.2015.05.026. Epub 2015 Jun 10.

PMID:
26118620

Supplemental Content

Support Center